# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000058
Filing Date
2025-01-10
Accepted
2025-01-10 14:19:12
Documents
79
Period of Report
2024-11-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | lxrp_10q.htm iXBRL | 10-Q | 808431
2 | EX-10.4 | lxrp_ex104.htm | EX-10.4 | 495466
3 | EX-10.5 | lxrp_ex105.htm | EX-10.5 | 134565
4 | CERTIFICATION | lxrp_ex311.htm | EX-31.1 | 9936
5 | CERTIFICATION | lxrp_ex312.htm | EX-32.2 | 9399
6 | CERTIFICATION | lxrp_ex321.htm | EX-32.1 | 4693
7 | CERTIFICATION | lxrp_ex322.htm | EX-31.2 | 4746
13 |  | lxrp_ex104img25.jpg | GRAPHIC | 3667
14 |  | lxrp_ex104img28.jpg | GRAPHIC | 3667
15 |  | lxrp_ex104img27.jpg | GRAPHIC | 3667
16 |  | lxrp_ex104img26.jpg | GRAPHIC | 3667
17 |  | lxrp_ex104img24.jpg | GRAPHIC | 3667
| Complete submission text file | 0001640334-25-000058.txt |  | 5415641

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20241130.xsd | EX-101.SCH | 49218
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20241130_lab.xml | EX-101.LAB | 283575
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20241130_cal.xml | EX-101.CAL | 46723
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20241130_pre.xml | EX-101.PRE | 237264
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20241130_def.xml | EX-101.DEF | 124017
82 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10q_htm.xml | XML | 764998

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 25522322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)